Seminars in Immunology

Papers
(The TQCC of Seminars in Immunology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Exploiting antifungal immunity in the clinical context217
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity177
Editorial Board88
Differential immune responses behind different celiac disease manifestations75
Three’s company: The cooperative signals behind the differentiation of Th9 cells69
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells67
Cellular stress and macrophage activation66
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity65
Editorial Board62
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi59
Aging of lymphoid stromal architecture impacts immune responses56
Resolving inflammatory links between myocardial infarction and vascular dementia54
Pyroptosis modulation by bacterial effector proteins52
Microbial metabolites and immunotherapy: Basic rationale and clinical indications51
Local and Cell-intrinsic complement: The new player in cancer progression51
Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges50
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?48
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity47
Immunity to pathogenic fungi in the eye44
Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)43
The noncanonical inflammasome-induced pyroptosis and septic shock42
Pyroptosis: A road to next-generation cancer immunotherapy41
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease41
Pyroptosis and the cellular consequences of gasdermin pores38
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity35
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment34
Interplay between the complement system and other immune pathways in the tumor microenvironment34
Immunity to fungi: Editorial overview32
Western diet influences on microbiome and carcinogenesis32
Neuroimmune interactions between itch neurons and skin microbes30
Specialized pro-resolving mediators as modulators of immune responses30
Cellular and molecular diversity in spondyloarthritis30
Autoimmune diabetes and targets for immunomodulation29
Cellular and molecular diversity in Sjogren’s syndrome salivary glands: Towards a better definition of disease subsets29
Interleukin-1β and cancer immune response27
The paradox of aging: Aging-related shifts in T cell function and metabolism27
The evolving biology of cross-presentation27
TREM2: A new player in the tumor microenvironment26
Adaptive NK cell response to human cytomegalovirus: Facts and open issues26
Antigen discovery for the development of cancer immunotherapy25
Recent developments in C3-targeted complement therapeutics24
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases24
Thymus aging and immune reconstitution, progresses and challenges23
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy23
Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases22
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinic22
T cell control of SARS-CoV-2: When, which, and where?22
Introduction to the Special Issue: Nutrition, microbiota and immunity22
Sialic acid and Siglec receptors in tumor immunity and immunotherapy22
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination21
Targeting the tissue-complosome for curbing inflammatory disease21
T cell fate decisions during memory cell generation with aging21
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs21
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity20
The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders20
Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity20
Editorial Board19
Regulation of innate immune system function by the microbiome: Consequences for tumor immunity and cancer immunotherapy19
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy19
The glycoimmune landscape in health and disease19
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?19
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells19
0.061908006668091